{"id":"https://openalex.org/W2004104079","doi":"https://doi.org/10.1016/j.juro.2011.02.1107","title":"1070 DEVELOPMENT OF A RAPAMYCIN SENSITIVE CELL LINE FROM UROTHELIAL CARCINOMA WITH SARCOMATOID FEATURES","display_name":"1070 DEVELOPMENT OF A RAPAMYCIN SENSITIVE CELL LINE FROM UROTHELIAL CARCINOMA WITH SARCOMATOID FEATURES","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2004104079","doi":"https://doi.org/10.1016/j.juro.2011.02.1107","mag":"2004104079"},"language":"en","primary_location":{"id":"doi:10.1016/j.juro.2011.02.1107","doi":"https://doi.org/10.1016/j.juro.2011.02.1107","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2011.02.1107","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111908728","display_name":"Edward C. Diaz","orcid":"https://orcid.org/0000-0003-2835-8736","observed_orcids":["https://orcid.org/0000-0003-2835-8736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward Diaz","raw_affiliation_strings":["Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022804099","display_name":"Christina Barbara Ching","orcid":"https://orcid.org/0000-0002-3396-4215","observed_orcids":["https://orcid.org/0000-0002-3396-4215"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Ching","raw_affiliation_strings":["Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland, OH","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002024579","display_name":"Donna Elizabeth Hansel","orcid":"https://orcid.org/0000-0001-7860-4881","observed_orcids":["https://orcid.org/0000-0001-7860-4881"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donna Hansel","raw_affiliation_strings":["Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland, OH","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.13083806,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"185","issue":"4S","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.005400000140070915,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8989999890327454},{"id":"https://openalex.org/keywords/sarcomatoid-differentiation","display_name":"sarcomatoid differentiation","score":0.8429999947547913},{"id":"https://openalex.org/keywords/squamous-differentiation","display_name":"squamous differentiation","score":0.871999979019165},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.902999997138977},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.9679999947547913},{"id":"https://openalex.org/keywords/serum-free-cell-culture","display_name":"serum-free cell culture","score":0.8259999752044678},{"id":"https://openalex.org/keywords/cell-line-development","display_name":"cell line development","score":0.6830000281333923},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.4860000014305115},{"id":"https://openalex.org/keywords/p63","display_name":"p63","score":0.7149999737739563},{"id":"https://openalex.org/keywords/cytokeratin-7","display_name":"CK7","score":0.6639999747276306},{"id":"https://openalex.org/keywords/cytokeratin-20","display_name":"CK20","score":0.6259999871253967},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.5339999794960022},{"id":"https://openalex.org/keywords/cell-immortalization","display_name":"cell immortalization","score":0.41499999165534973},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.453000009059906},{"id":"https://openalex.org/keywords/cell-block","display_name":"cell block","score":0.3050000071525574},{"id":"https://openalex.org/keywords/tumor-markers","display_name":"tumor markers","score":0.33000001311302185},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.4740000069141388},{"id":"https://openalex.org/keywords/rapamycin-sensitivity","display_name":"rapamycin sensitivity","score":0.4970000088214874},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C2910041100","wikidata":"https://www.wikidata.org/wiki/Q11878994","display_name":"Urothelial Cell","level":4,"score":0.7257323265075684},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.686386227607727},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.618507981300354},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.6042600274085999},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5816301107406616},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.5711958408355713},{"id":"https://openalex.org/C3019882237","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial carcinoma","level":4,"score":0.4964783787727356},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.47900670766830444},{"id":"https://openalex.org/C64979461","wikidata":"https://www.wikidata.org/wiki/Q3151077","display_name":"Contact inhibition","level":3,"score":0.4577163755893707},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.42694026231765747},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3939543664455414},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.3652888536453247},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.32283344864845276},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28452494740486145},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21866530179977417},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.19010260701179504},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.16829192638397217},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09413892030715942}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.juro.2011.02.1107","doi":"https://doi.org/10.1016/j.juro.2011.02.1107","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.juro.2011.02.1107","pdf_url":null,"source":{"id":"https://openalex.org/S30525748","display_name":"The Journal of Urology","issn_l":"0022-5347","issn":["0022-5347","1527-3792"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Urology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2101967561","https://openalex.org/W2054387168","https://openalex.org/W1971938906","https://openalex.org/W2317720916","https://openalex.org/W1995589496","https://openalex.org/W1498637512","https://openalex.org/W2076975629","https://openalex.org/W2111065321","https://openalex.org/W2320287609","https://openalex.org/W2410796482"],"abstract_inverted_index":{"You":[0],"have":[1],"accessJournal":[2],"of":[3,93,128,132,154,161,195,230,251,268,348,356,439,465,475],"UrologyBladder":[4],"Cancer:":[5],"Basic":[6],"Research1":[7],"Apr":[8],"20111070":[9],"DEVELOPMENT":[10],"OF":[11],"A":[12],"RAPAMYCIN":[13],"SENSITIVE":[14],"CELL":[15],"LINE":[16],"FROM":[17],"UROTHELIAL":[18],"CARCINOMA":[19],"WITH":[20],"SARCOMATOID":[21],"FEATURES":[22],"Edward":[23,30,506],"Diaz,":[24],"Christina":[25,41,515],"Ching,":[26],"and":[27,52,136,157,186,213,241,248,290,324,410,441,469,484,502],"Donna":[28,53,524],"Hansel":[29,55,525],"DiazEdward":[31],"Diaz":[32,507],"Cleveland,":[33,44,56,508,517,526],"OH":[34,45,57,509,518,527],"More":[35,46,58,510,519,528],"articles":[36,47,59,511,520,529],"by":[37,48,60,479,497,512,521,530],"this":[38,49,61,372,454,466,472,513,522,531],"author":[39,50,62,514,523,532],",":[40,51],"ChingChristina":[42],"Ching":[43,516],"HanselDonna":[54],"View":[63],"All":[64,534],"Author":[65],"Informationhttps://doi.org/10.1016/j.juro.2011.02.1107AboutPDF":[66],"ToolsAdd":[67],"to":[68,143,255,284,379,461,471],"favoritesDownload":[69],"CitationsTrack":[70],"CitationsPermissionsReprints":[71],"ShareFacebookTwitterLinked":[72],"InEmail":[73],"INTRODUCTION":[74],"AND":[75],"OBJECTIVES":[76],"Multiple":[77],"commercial":[78],"cell":[79,110,148,196,231,245,253,331,337,373,432,467],"lines":[80,111],"for":[81,228,310,314,318,322,327,391,396,407,413],"urothelial":[82,94,109,155,334,430],"carcinoma":[83],"(UC)":[84],"exist,":[85],"but":[86],"few":[87,108],"were":[88,190,225],"developed":[89],"from":[90,150,173,209,367,371,435],"aggressive":[91,152,235,437,473],"variants":[92],"carcinoma,":[95,156],"such":[96],"as":[97],"those":[98],"with":[99,179,183,220,274,359],"sarcomatoid":[100,184],"or":[101],"squamous":[102,187],"features.":[103],"There":[104],"are":[105],"also":[106],"very":[107],"that":[112,443],"can":[113,444],"be":[114,445],"sustained":[115,446],"in":[116,138,198,215,234,261,272,280,341,353,376,421,447,453],"a":[117,124,145,174,244,264,281,357,428],"serum":[118,146,216,298,448],"free":[119,217,299,449],"environment.":[120],"Recent":[121],"studies":[122],"support":[123],"relationship":[125],"between":[126],"regulation":[127],"the":[129,159,210,252,330,342,354,380,462],"mammalian":[130],"target":[131],"rapamycin":[133,271,392,408],"(mTOR)":[134],"pathway":[135],"carcinogenesis":[137],"UC.":[139,476],"Our":[140],"objective":[141],"was":[142,171,207,258,292,419],"develop":[144],"independent":[147],"line":[149,254,338,374,433],"an":[151,199,436],"variant":[153,438,474],"assess":[158],"effect":[160],"mTOR":[162,256,381,457],"inhibition":[163,257],"on":[164],"these":[165],"cells.":[166],"METHODS":[167],"The":[168,204,223,336],"primary":[169],"specimen":[170],"obtained":[172],"67":[175],"yo":[176],"caucasian":[177],"female":[178],"high":[180],"grade":[181],"UC":[182,236,440],"features":[185],"differentiation.":[188],"Cells":[189,278],"immortalized":[191],"using":[192,243,263],"two":[193],"rounds":[194],"propagation":[197],"immune":[200],"deficient":[201],"mouse":[202,343],"model.":[203,345],"final":[205],"tumor":[206,358,386,400],"harvested":[208],"mouse,":[211],"dissociated,":[212],"grown":[214],"conditions":[218,300],"supplemented":[219],"growth":[221,355],"factors.":[222],"cells":[224,351],"then":[226,259],"tested":[227,260],"expression":[229],"markers":[232],"found":[233],"(CK7,":[237],"CK20,":[238,319],"p63,":[239,311],"p53,":[240,323],"Ker903)":[242],"block":[246,305],"protocol":[247],"immunostaining.":[249],"Sensitivity":[250],"vivo":[262,377],"double":[265],"arm":[266,393],"trial":[267],"placebo":[269,397,414],"vs":[270],"mice":[273],"established":[275],"tumors.":[276],"RESULTS":[277],"grew":[279],"monolayer":[282],"adherent":[283],"standard":[285],"tissue":[286],"culture":[287],"plates.":[288],"Morphology":[289],"viability":[291],"maintained":[293],"after":[294,364,402],"multiples":[295],"passages":[296],"within":[297],"(Over":[301],"20":[302],"passages).":[303],"Cell":[304],"revealed":[306],"approximately":[307],"30%":[308],"staining":[309,313,317,321,326],"100%":[312,320],"CK7,":[315],"0%":[316],"40%":[325],"Ker903,":[328],"confirming":[329],"line's":[332],"human":[333],"origin.":[335],"demonstrated":[339,375],"tumorigenicity":[340],"xenograft":[344],"Single":[346],"injection":[347],"3":[349],"million":[350],"resulted":[352],"max":[360],"1":[361],"cm":[362],"dimension":[363],"31":[365],"days":[366],"inoculation.":[368],"Tumors":[369],"derived":[370,434],"sensitivity":[378],"inhibitor,":[382],"rapamycin.":[383],"Starting":[384],"average":[385],"volume":[387,401],"was:":[388,404],"231.5":[389],"cm3":[390,395,406,412],"302.4":[394],"arm.":[398,415],"Average":[399],"treatment":[403,423],"336":[405],"arm,":[409],"682":[411],"No":[416],"metastatic":[417],"disease":[418],"present":[420],"either":[422],"group.":[424],"CONCLUSIONS":[425],"This":[426],"provides":[427],"unique":[429],"cancer":[431],"one":[442],"conditions.":[450],"Preliminary":[451],"results":[452],"study":[455],"suggest":[456],"signaling":[458],"is":[459],"important":[460],"proliferative":[463],"potential":[464],"line,":[468],"possibly":[470],"\u00a9":[477],"2011":[478,496],"American":[480,498],"Urological":[481,499],"Association":[482,500],"Education":[483,501],"Research,":[485,503],"Inc.FiguresReferencesRelatedDetails":[486],"Volume":[487],"185Issue":[488],"4SApril":[489],"2011Page:":[490],"e430":[491],"Advertisement":[492,535,536],"Copyright":[493],"&":[494],"Permissions\u00a9":[495],"Inc.MetricsAuthor":[504],"Information":[505],"Expand":[533],"PDF":[537],"downloadLoading":[538],"...":[539]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}